Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD

Blood

Volumn 105, Issue 5, 2005, Pages 2220-2226

  Ermann, Joerg ^b   Hoffmann, Petra ^b   Edinger, Matthias ^b   Dutt, Suparna ^b   Blankenberg, Francis G ^b   Higgins, John P ^b   Negrin, Robert S ^b   Fathman, C Garrison ^b   Strober, Samuel ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

L SELECTIN; INTERLEUKIN 2 RECEPTOR; LEUKOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROTECTION; CELL SUBPOPULATION; CELL TRANSFER; COLON INJURY; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE; MESENCHYME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; T LYMPHOCYTE; ACUTE DISEASE; ADOPTIVE IMMUNOTHERAPY; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW TRANSPLANTATION; C57BL MOUSE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL MOTION; CYTOLOGY; DISEASE MODEL; HISTOCOMPATIBILITY; IMMUNOLOGICAL TOLERANCE; METHODOLOGY; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION; TRANSPLANTATION;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD; BONE MARROW TRANSPLANTATION; CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY; IMMUNE TOLERANCE; IMMUNOTHERAPY, ADOPTIVE; L-SELECTIN; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTE SUBSETS;

EID: 14944346738     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-05-2044     Document Type: Article

References (30)

1. Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med. 2002;196:389-399.
2. Taylor PA. Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood. 2002;99:3493-3499.
3. Cohen JL. Trenado A, Vasey D, Klatzmann D. Salomon BL CD4(+)CD25(+) immunoregulatory T cells: new therapeutics for graft-versus-host disease. J Exp Med. 2002;196:401-406.
4. Edinger M, Hoffmann P, Ermann J, et al. CD4 + CD25 + regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med. 2003;9:1144-1150.
5. Trenado A, Charlotte F, Fisson S, et al. Recipienttype specific CD4 + CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest. 2003;112:1688-1696.
6. Jones SC, Murphy GF, Korngold R. Post-hemato-poietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response. Biol Blood Marrow Transplant. 2003;9:243-256.
7. Butcher EC. Picker LJ. Lymphocyte homing and homeostasis. Science. 1996;272:60-66.
8. Anderson BE, McNiff J, Van J, et al. Memory CD4+ T cells do not induce graft-versus-host disease. J Clin Invest. 2003;112:101-108.
9. Chen BJ, Cui X, Sempowski GD, Liu C, Chao NJ. Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease. Blood. Prepublished on October 9, 2003, as DOI 10.1182/blood-2003-08-2987. (Now available as Blood. 2004; 103:1534-1541).
10. Kuniyasu Y, Takahashi T, Itoh M, Shimizu J. Toda G. Sakaguchi S. Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int Immunol. 2000;12:1145-1155.
11. Thornton AM. Shevach EM. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol. 2000;164: 183-190.
12. Szanya V, Ermann J, Taylor C. Holness C, Fathman CG. The subpopulation of CD4(+)CD25(+) splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J Immunol. 2002;169:2461-2465.
13. Fu S, Yopp AC. Mao X, et al. CD4 + CD25+ CD62L+ T-regulatory cell subset has optimal suppressive and proliferative potential. Am J Transplant. 2004;4:65-78.
14. Ridolfi R, Riccobon A. Galassi R, et al. Evaluation of in vivo labelled dendritic cell migration in cancer patients. J Transi Med. 2004;2:27.
15. Eberl G, MacDonald HR. Rapid death and regeneration of NKT cells in anti-CD3epsilon- or IL-12-treated mice: a major role for bone marrow in NKT cell homeostasis. Immunity. 1998;9:345-353.
16. Ermann J, Szanya V, Ford GS. Paragas V, Fathman CG. Lejon K. Cd4(+)cd25(+) T cells facilitate the induction of T cell anergy. J Immunol. 2001;167:4271-4275.
17. McHugh RS, Whitters MJ, Piccirillo CA, et al. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity. 2002;16:311-323.
18. Shimizu J. Yamazaki S, Takahashi T, Ishida Y. Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol. 2002;3:135-142.
19. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003;4:330-336.
20. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057-1061.
21. Lan F, Zeng D, Huie P. Higgins JP. Strober S. Allogeneic bone marrow cells that facilitate complete chimerism and eliminate tumor cells ex press both CD8 and T-cell antigen receptoralphabeta. Blood. 2001;97:3458-3465.
22. Ferrara J. Location, location, location. Nat Immunol.2003;4:103-104.
23. M'Rini C, Cheng G. Schweitzer C. et al. A novel endothelial L-selectin ligand activity in lymph node medulla that is regulated by alpha(1,3)-fu- cosyltransferase-IV. J Exp Med. 2003;198:1301-1312.
24. Li B. New JY. Yap EH. Lu J, Chan SH, Hu H. Blocking L-selectin and alpha4-integrin changes donor cell homing pattern and ameliorates murine acute graft versus host disease. Eur J Immunol. 2001;31:617-624.
25. Li B, New JY, lay YK, et al. Delaying acute graft-versus-host disease in mouse bone marrow transplantation by treating donor cells with antibodies directed at I-selectin and alpha4-integrin prior to infusion. Scand J Immunol. 2004;59:464-468.
26. Bradley LM, Duncan DD, Tonkonogy S, Swain SL. Characterization of antigen-specific CD4+ effector T cells in vivo: immunization results in a transient population of MEL-14-, CD45RB- helper cells that secretes interleukin 2 (IL-2), IL-3, IL-4, and Interferon gamma. J Exp Med. 1991;174: 547-559.
27. Walker LS, Chodos A, Eggena M, Dooms H, Abbas AK. Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J Exp Med. 2003;198:249-258.
28. Apostolou I, Sarukhan A. Klein L, von Boehmer H. Origin of regulatory T cells with known specificity for antigen. Nat Immunol. 2002;3:756-763.
29. Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med. 1998;188:287-296.
30. Fisson S, Darrasse-Jeze G, Litvinova E, et al. Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J Exp Med. 2003;198:737-746.